Search Results - "Kis, Olena"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates by Kis, Olena, Kaedbey, Rayan, Chow, Signy, Danesh, Arnavaz, Dowar, Mark, Li, Tiantian, Li, Zhihua, Liu, Jessica, Mansour, Mark, Masih-Khan, Esther, Zhang, Tong, Bratman, Scott V., Oza, Amit M., Kamel-Reid, Suzanne, Trudel, Suzanne, Pugh, Trevor J.

    Published in Nature communications (11-05-2017)
    “…The requirement for bone-marrow aspirates for genomic profiling of multiple myeloma poses an obstacle to enrolment and retention of patients in clinical…”
    Get full text
    Journal Article
  2. 2
  3. 3

    pH dependence of organic anion-transporting polypeptide 2B1 in Caco-2 cells: potential role in antiretroviral drug oral bioavailability and drug-drug interactions by Kis, Olena, Zastre, Jason A, Ramaswamy, Manisha, Bendayan, Reina

    “…Human intestinal epithelium expresses a number of drug efflux and influx transporters that can restrict and/or facilitate intestinal drug uptake during…”
    Get more information
    Journal Article
  4. 4

    Interactions between phytochemical components of Sutherlandia frutescens and the antiretroviral, atazanavir in vitro: implications for absorption and metabolism by Müller, Adrienne C, Patnala, Srinivas, Kis, Olena, Bendayan, Reina, Kanfer, Isadore

    “…African traditional medicinal plants, such as Sutherlandia frutescens have the potential to interact pharmacokinetically with the protease inhibitor class of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The complexities of antiretroviral drug–drug interactions: role of ABC and SLC transporters by Kis, Olena, Robillard, Kevin, Chan, Gary N.Y, Bendayan, Reina

    “…Treatment of human immunodeficiency virus (HIV) infection involves a combination of several antiviral agents belonging to different pharmacological classes…”
    Get full text
    Journal Article
  7. 7

    Sclerosing TSC1 mutated renal cell carcinoma: An unusual pattern mimicking MITF family translocation renal cell carcinoma by Williamson, Sean R., Cardili, Leonardo, Whiteley, Lisa J., Sanchez, Jessica, Kis, Olena

    Published in Genes chromosomes & cancer (01-10-2020)
    “…The tuberous sclerosis genes and MTOR are increasingly being found to have important roles in novel subtypes of renal cancer, particularly emerging entities…”
    Get full text
    Journal Article
  8. 8

    HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition by Kis, Olena, Sankaran-Walters, Sumathi, Hoque, M Tozammel, Walmsley, Sharon L, Dandekar, Satya, Bendayan, Reina

    Published in Antimicrobial agents and chemotherapy (01-05-2016)
    “…This study investigated the effects of HIV-1 infection and antiretroviral therapy (ART) on the expression of intestinal drug efflux transporters, i.e.,…”
    Get full text
    Journal Article
  9. 9

    In Vitro and In Situ Evaluation of pH-Dependence of Atazanavir Intestinal Permeability and Interactions with Acid-Reducing Agents by Kis, Olena, Walmsley, Sharon L., Bendayan, Reina

    Published in Pharmaceutical research (01-09-2014)
    “…Purpose The objectives of this study were to evaluate the effects of intestinal lumen pH, food intake, and acid-reducing agents on the intestinal permeability…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters by Hoque, M Tozammel, Kis, Olena, De Rosa, María F, Bendayan, Reina

    Published in Antimicrobial agents and chemotherapy (01-05-2015)
    “…The objectives of this study were to investigate raltegravir transport across several blood-tissue barrier models and the potential interactions with drug…”
    Get full text
    Journal Article
  12. 12

    Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug Interactions by Kis, Olena, Zastre, Jason A., Hoque, Md. Tozammel, Walmsley, Sharon L., Bendayan, Reina

    Published in Pharmaceutical research (01-04-2013)
    “…ABSTRACT Purpose To investigate the role of membrane-associated drug transporters in regulating the intestinal absorption of the HIV-1 protease inhibitor,…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Drug transporters at brain barriers: expression and regulation by neurological disorders by Ashraf, Tamima, Kis, Olena, Banerjee, Nilasha, Bendayan, Reina

    “…Drug transport in the central nervous system can be highly regulated by the expression of numerous influx and efflux transport proteins not only at the…”
    Get more information
    Journal Article
  16. 16

    Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing by Chow, Signy, Kis, Olena, Mulder, David T, Danesh, Arnavaz, Bruce, Jeff, Wang, Ting Ting, Reece, Donna, Bhalis, Nizar, Neri, Paola, Sabatini, Peter Jb, Keats, Jonathan, Trudel, Suzanne, Pugh, Trevor J

    Published in Life science alliance (01-01-2023)
    “…Multiple myeloma is a plasma cell neoplasm characterized by clonal immunoglobulin V(D)J signatures and oncogenic immunoglobulin gene translocations. Additional…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Abstract 615: Noninvasive diagnosis of actionable mutations by deep sequencing of circulating tumor DNA in multiple myeloma by Kaedbey, Rayan, Kis, Olena, Danesh, Arnavaz, Dowar, Mark, Li, Tiantian, Li, Zhihua, Liu, Jessica, Mansour, Mark, Sukhai, Mahadeo, Zhang, Tong, Kamel-Reid, Suzanne, Pugh, Trevor J., Trudel, Suzanne

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Abstract Background: Genome sequencing of multiple myeloma (MM) tumors has revealed recurrent mutations that serve as a fertile ground for targeted therapies…”
    Get full text
    Journal Article
  19. 19

    Complexity of Antiretroviral Drug-Drug Interactions in the Intestine: Role of Membrane-Associated Drug Transporters by Kis, Olena

    Published 01-01-2014
    “…Complex antiretroviral therapy has introduced new obstacles in the treatment of HIV infection such as management of drug-induced toxicities and drug-drug…”
    Get full text
    Dissertation
  20. 20